Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Mehlsen

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
European Heart Journal|January 8, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closurePeter S Sever, Neil R Poulter, Bjorn Dahlof, et al.
Lancet (London, England)|September 13, 2005
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialBjörn Dahlöf, Peter S Sever, Neil R Poulter, et al.
Pediatrics|November 24, 2017
4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 YearsDaron G Ferris, Rudiwilai Samakoses, Stanley L Block, et al.
Clinical Epidemiology|March 10, 2017
Cohort description: The Danish study of Functional DisordersThomas Meinertz Dantoft, Jeanette Frost Ebstrup, Allan Linneberg, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
European Heart Journal|January 8, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closurePeter S Sever, Neil R Poulter, Bjorn Dahlof, et al.
Lancet (London, England)|September 13, 2005
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialBjörn Dahlöf, Peter S Sever, Neil R Poulter, et al.
Pediatrics|November 24, 2017
4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 YearsDaron G Ferris, Rudiwilai Samakoses, Stanley L Block, et al.
Clinical Epidemiology|March 10, 2017
Cohort description: The Danish study of Functional DisordersThomas Meinertz Dantoft, Jeanette Frost Ebstrup, Allan Linneberg, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
Pageof 10